![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Departments of
*
Biochemistry and
Pathology and Animal Resources, Emory University, Atlanta, GA 30322
2To whom correspondence should be addressed.
Dietary sphingomyelin (SM) inhibits early stages of colon cancer (appearance of aberrant crypt foci, ACF) and decreases the proportion of adenocarcinomas vs. adenomas in 1,2-dimethylhydrazine (DMH)-treated CF1 mice. To elucidate the structural specificity of this inhibition, the effects of the other major sphingolipids in milk (glycosphingolipids) were determined. Glucosylceramide (GluCer), lactosylceramide (LacCer) and ganglioside GD3 were fed individually to DMH-treated (six doses of 30 mg/kg body weight) female CF1 mice at 0.025 or 0.1 g/100 g of the diet for 4 wk. All reduced the number of ACF by > 40% (P < 0.001), which is comparable to the reduction by SM in earlier studies. Immunohistochemical analysis of the colons revealed that sphingolipid feeding also reduced proliferation, with the most profound effect (up to 80%; P < 0.001) in the upper half of the crypts. Since the bioactive backbones of the glycosphingolipids (i.e., ceramide and other metabolites) are the likely mediators of these effects, the susceptibility of these complex sphingolipids to digestion in the colon was examined by incubating 500 µg of each sphingolipid with colonic segments from mice and analysis of substrate disappearance and product formation by tandem mass spectrometry. All of the sphingolipids (including SM) disappeared over time with a substantial portion appearing as ceramide. Partially hydrolyzed intermediates (such as GluCer from LacCer or GD3) were not detected, which suggests that the cleavage involves colonic (or microflora) endoglycosidases. In summary, consumption of dairy SM and glycosphingolipids suppresses colonic cell proliferation and ACF formation in DMH-treated mice; hence, many categories of sphingolipids affect these key events in colon carcinogenesis.
KEY WORDS: • proliferation • sphingomyelin • glycosphingolipids • colon cancer • mice
This article has been cited by other articles:
|
|
 |
|
  E. M. Schmelz, H. Xu, R. Sengupta, J. Du, S. Banerjee, F. H. Sarkar, A. K. Rishi, and A. P.N. Majumdar Regression of Early and Intermediate Stages of Colon Cancer by Targeting Multiple Members of the EGFR Family with EGFR-Related Protein Cancer Res., June 1, 2007; 67(11): 5389 - 5396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Morin, M. Britten, R. Jimenez-Flores, and Y. Pouliot Microfiltration of Buttermilk and Washed Cream Buttermilk for Concentration of Milk Fat Globule Membrane Components J Dairy Sci, May 1, 2007; 90(5): 2132 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. F. Graves, A. D. Beaulieu, and J. K. Drackley Factors Affecting the Concentration of Sphingomyelin in Bovine Milk J Dairy Sci, February 1, 2007; 90(2): 706 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Ahn, C.-C. Chang, and J. J. Schroeder Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents. Experimental Biology and Medicine, November 1, 2006; 231(10): 1664 - 1672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kono, J. L. Dreier, J. M. Ellis, M. L. Allende, D. N. Kalkofen, K. M. Sanders, J. Bielawski, A. Bielawska, Y. A. Hannun, and R. L. Proia Neutral Ceramidase Encoded by the Asah2 Gene Is Essential for the Intestinal Degradation of Sphingolipids J. Biol. Chem., March 17, 2006; 281(11): 7324 - 7331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Modrak, D. V. Gold, and D. M. Goldenberg Sphingolipid targets in cancer therapy. Mol. Cancer Ther., February 1, 2006; 5(2): 200 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Park, M. Suh, B. Thomson, A. B.R. Thomson, K. S. Ramanujam, and M. T. Clinin Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains Glycobiology, October 1, 2005; 15(10): 935 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Di Marzio, A. Di Leo, B. Cinque, D. Fanini, A. Agnifili, P. Berloco, M. Linsalata, D. Lorusso, M. Barone, C. De Simone, et al. Detection of Alkaline Sphingomyelinase Activity in Human Stool: Proposed Role as a New Diagnostic and Prognostic Marker of Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 856 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Symolon, E. M. Schmelz, D. L. Dillehay, and A. H. Merrill Jr. Dietary Soy Sphingolipids Suppress Tumorigenesis and Gene Expression in 1,2-Dimethylhydrazine-Treated CF1 Mice and ApcMin/+ Mice J. Nutr., May 1, 2004; 134(5): 1157 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Castillo and D. Teegarden Sphingosine-1-Phosphate Inhibition of Apoptosis Requires Mitogen-Activated Protein Kinase Phosphatase-1 in Mouse Fibroblast C3H10T1/2 Cells J. Nutr., November 1, 2003; 133(11): 3343 - 3349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sugawara, M. Kinoshita, M. Ohnishi, J. Nagata, and M. Saito Digestion of Maize Sphingolipids in Rats and Uptake of Sphingadienine by Caco-2 Cells J. Nutr., September 1, 2003; 133(9): 2777 - 2782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Silins, M. Nordstrand, J. Hogberg, and U. Stenius Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo Carcinogenesis, June 1, 2003; 24(6): 1077 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Ahn and J. J. Schroeder Sphingoid Bases and Ceramide Induce Apoptosis in HT-29 and HCT-116 Human Colon Cancer Cells Experimental Biology and Medicine, May 1, 2002; 227(5): 345 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Cheng, A. Nilsson, E. Tomquist, and R.-D. Duan Purification, characterization, and expression of rat intestinal alkaline sphingomyelinase J. Lipid Res., February 1, 2002; 43(2): 316 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Schmelz, P. C. Roberts, E. M. Kustin, L. A. Lemonnier, M. C. Sullards, D. L. Dillehay, and A. H. Merrill Jr. Modulation of Intracellular {beta}-Catenin Localization and Intestinal Tumorigenesis in Vivo and in Vitro by Sphingolipids Cancer Res., September 1, 2001; 61(18): 6723 - 6729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Miller, J. K. Jarvis, and L. D. McBean The Importance of Meeting Calcium Needs with Foods J. Am. Coll. Nutr., April 1, 2001; 20(2): 168S - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Anti, A Armuzzi, S Morini, E Iascone, G Pignataro, C Coco, R Lorenzetti, M Paolucci, M Covino, A Gasbarrini, et al. Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas Gut, February 1, 2001; 48(2): 238 - 246. [Abstract] [Full Text] [PDF]
|
|
